← back to search

Yile Zhou

Sun Yat-sen University · CN
Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Epigenetics and DNA Methylation.
h-index
21
citations
1,766
works
98
NIH funding
primary concept
email

Recent publications

Telocyte-derived exosomes promote angiogenesis and alleviate acute respiratory distress syndrome via JAK/STAT-miR-221-E2F2 axis
Molecular Biomedicine 2025cited by 3position: middledoi
Efficacy and safety of OB756 (a novel selective JAK2 inhibitor) for essential thrombocythemia in patients intolerant of or resistant to hydroxyurea or intolerant of interferon: A phase 2, open‐label, multicenter study
Cancer 2025cited by 1position: middledoi
Indirect treatment comparison of novel JAK2 Inhibitor OB756 versus ruxolitinib in polycythaemia vera with splenomegaly
Blood 2025cited by 0position: middledoi
Efficacy and safety of OB756 (a Novel Selective JAK2 Inhibitor) for essential thrombocythemia in patients intolerant or resistant to hydroxyurea or interferon: A phase II, open-label, multicenter study
Blood 2025cited by 0position: middledoi
A Novel JAK2 Inhibitor OB756 in Treatment of Janus Kinase Inhibitor-Naive Patients with Myelofibrosis: A Phase 1/2, Open-Label, Multicenter Study
Blood 2024cited by 1position: firstdoi
First in-Class JAK2 Inhibitor OB756 Therapy for Patients with Polycythemia Vera : A Phase 2, Open-Label, Multicenter Study
Blood 2024cited by 0position: middledoi
Tregs dysfunction aggravates postoperative cognitive impairment in aged mice
Journal of Neuroinflammation 2023cited by 56position: firstdoi
Metformin Protects Against Diabetes-Induced Cognitive Dysfunction by Inhibiting Mitochondrial Fission Protein DRP1
Frontiers in Pharmacology 2022cited by 41position: middledoi
Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally
Nature 2019cited by 697position: middledoi
Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation
Asian Journal of Pharmaceutical Sciences 2019cited by 67position: middledoi
6-O-angeloylplenolin exerts neuroprotection against lipopolysaccharide-induced neuroinflammation in vitro and in vivo
Acta Pharmacologica Sinica 2019cited by 49position: firstdoi
Centipeda minima extract exerts antineuroinflammatory effects via the inhibition of NF-κB signaling pathway
Phytomedicine 2019cited by 36position: middledoi
Ethanol Extract of <i>Centipeda minima</i> Exerts Antioxidant and Neuroprotective Effects via Activation of the Nrf2 Signaling Pathway
Oxidative Medicine and Cellular Longevity 2019cited by 32position: middledoi
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes
Cancer Discovery 2018cited by 52position: middledoi
Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials
PLoS ONE 2018cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jie Jin · Taiyuan University of Technology4 papers (2024–2025)Qingchi Liu · Hebei Medical University4 papers (2024–2025) · 4 papers (2024–2025) · 3 papers (2025–2025)Bingbing Wen · Arizona State University3 papers (2024–2025)Zongjiu Jiao · Hebei Medical University3 papers (2024–2025)Feng Zhang · Qingdao University3 papers (2025–2025) · 3 papers (2024–2025) · 3 papers (2024–2025)Yong‐Xian Cheng · Shenzhen University3 papers (2019–2019)Tiejun Gong · Harbin Medical University3 papers (2025–2025) · 3 papers (2024–2025)Qi Wang · Hebei Medical University3 papers (2018–2019)Yongqiang Liu · Guangzhou University of Chinese Medicine3 papers (2019–2019)Wei Liu · Guangzhou University of Chinese Medicine3 papers (2019–2019)Tiejun Gong · Harbin Medical University2 papers (2024–2024) · 2 papers (2025–2025)Su-Fen Wei · Guangzhou University of Chinese Medicine2 papers (2019–2019)Hu Zhou · Zhengzhou University2 papers (2025–2025)Yong‐Ming Yan · Guangzhou University of Chinese Medicine2 papers (2019–2019)